»Der har været en periode, hvor vi skulle kalde vores produktionsfolk ind for at producere lidt ekstra eller lave nogle ...

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...

Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Pharma brands achieved the most impressions from ABC and saw a year-over-year increase in impressions from cable channels like Fox News, CNN and MSNBC.

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Record Inventory Increase Meets Growing Consumer Demand for Healthcare Cost-Saving SolutionsSurge Driven by Ozempic and Zepbound Prescription ...

Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.

A federal judge’s ruling restricts compounding pharmacies from producing generic Zepbound, sparking concerns over affordability ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

The health regulator announced last month that there was no longer a shortage of Novo's Wegovy and diabetes drug Ozempic, ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...